Pad­lock share­hold­ers sue Bris­tol My­ers over mile­stone dis­pute af­ter 2016 ac­qui­si­tion

For­mer share­hold­ers in au­toim­mune biotech ac­quired by Bris­tol My­ers Squibb are su­ing the large phar­ma for what they claim are missed mile­stone pay­ments and ma­neu­vers …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER